Scapular WingingNCT07344272
The Effects of Proprioceptive Neuromuscular Facilitation
A study testing Proprioceptive neuromuscular facilitation in people with Scapular Winging, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).
Trial summary
This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging. Read more about this study
- Who is it for?
- Ages 20 to 40 years
- Conditions the study is for
- Scapular Winging
- What is being tested?
- Proprioceptive neuromuscular facilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Feb 2026to 15 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Volunteering to participate in the study.
- Presenting with bilateral scapular winging (Scapular winging will be evaluated by measuring the distance between the inferior angle of the scapula and the thoracic wall using a scapulometer; a distance of ≥2 cm is considered as winging).
Who cannot join
- Presence of long thoracic nerve palsy.
- Having undergone shoulder surgery within the last 12 months or having an acute shoulder injury (e.g., rotator cuff tear, dislocation, labral pathology, etc.).
- Presence of scapulothoracic bursitis, fractures, tumors, or structural deformities in the scapular/thoracic region.
- Having received regular scapular or shoulder rehabilitation within the last 6 months.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effects of Proprioceptive Neuromuscular Facilitation on Shoulder Girdle Function and Quality of Life in Individuals With Scapular Winging
This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging.
Read the detailed description
Scapular stability on the thorax is fundamental for maintaining proper upper extremity function. The loss of this stability manifests clinically as scapular winging, a pathological condition characterized by the prominent protrusion of the medial (vertebral) border and/or the inferior angle of the scapula away from the thorax.
PNF can target the underlying impairment of scapular dysfunction by activating the muscle synergies required for scapulothoracic stability more powerfully and coordinately through resisted diagonal movements.
Therefore, the implementation and testing of PNF protocols are of critical importance, as this method can enhance functional strength and coordination, contributing to better clinical outcomes and improved quality of life in individuals with scapular winging.
Therefore, this study aims to investigate the effects of PNF on shoulder girdle function and quality of life in individuals with scapular winging.
In this study, designed as a randomized controlled trial, one group will receive PNF in scapular diagonals for approximately 20-30 minutes, three days a week, for a total of five weeks, to ensure scapular positioning and increase the tone of the surrounding muscles.
The control group will receive no intervention during this period.
Before (pre-test) and after (post-test) the study, participants in both groups will be evaluated using the Scapular Isometric Pinch Test for scapular muscle endurance; the Lateral Scapular Slide Test for scapular position; the Rounded Shoulder Posture Assessment for shoulder posture; the Disabilities of the Arm, Shoulder, and Hand Questionnaire for upper extremity functional level; and the Short Form-36 for quality of life.
- Conditions
- Scapular Winging
- Being tested
- Proprioceptive neuromuscular facilitation
- Keywords
- Functional status, Neuromuscular effect, Proprioceptive neuromuscular facilitation, Quality of life, Scapula
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Proprioceptive neuromuscular facilitationOther
The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Proprioceptive Neuromuscular Facilitation Group | Active comparator | The Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes. Receives: Other: Proprioceptive neuromuscular facilitation |
| Control Group | No intervention | The Control Group will receive no intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Biodex System 3 Pro
Isokinetic strength measurement of the shoulder girdle muscles will be performed using a Biodex System 3 Pro isokinetic dynamometer. The measurements will be conducted in a diagonal plane specifically determined to align with scapular patterns, utilizing a concentric-concentric mode at two different angular velocities: 60°/s and 180°/s. For each test, participants will perform three trial sets; the peak torque values obtained from each set will be normalized to body weight (Nm/kg) and averaged for statistical analysis. During the test protocol, participants will be securely positioned using stabilization straps to ensure arm and trunk stability. Prior to the measurements, a device orientation and warm-up session (e.g., three practice/familiarization sets) will be conducted, followed by the actual data collection.
Measured: one week
Secondary outcomes (4)
Scapular Isometric Pinch Test
The scapular stabilizer muscles' endurance will be evaluated using the Scapular Isometric Pinch Test. During the test, participants will be asked to maintain the scapula in a bilateral retraction position and will be verbally encouraged to sustain the position for as long as they can maintain a maximal isometric contraction. The endurance time will be recorded in seconds.
Measured: one week
The Lateral Scapular Slide Test
The Lateral Scapular Slide Test will be used to evaluate scapular dyskinesis. During the test, the participant will be positioned with their back to the researcher. The assessment will be performed bilaterally in three different upper extremity positions: i) 0° of abduction with the arms in a neutral position, (ii) 45° of abduction with the hands placed on the hips and the thumbs pointing posteriorly, and (iii) 90° of abduction with the shoulders parallel to the floor and the arms held in maximum internal rotation. In all three positions, the scapular position will be determined by measuring the distance between the inferior angle of the scapula and the spinous processes of the thoracic vertebrae.
Measured: one week
Disabilities of the Arm, Shoulder, and Hand Questionnaire
The functional status of the upper extremity will be evaluated using the Disabilities of the Arm, Shoulder, and Hand Questionnaire. The Disabilities of the Arm, Shoulder, and Hand Questionnaireis a 30-item self-report scale that measures activities of daily living, symptom severity, and social/role functioning related to the upper extremity. Participants rate each item on a scale from 1 (no difficulty/no symptom) to 5 (unable to do/severe symptoms). The total score is transformed into a 0-100 range based on the item averages; higher scores indicate greater functional impairment.
Measured: one week
Short Form-36
Quality of life will be evaluated using the Short Form-36. The Short Form-36 assesses eight distinct health domains categorized under two main component summaries: Physical Functioning, Role Limitations due to Physical Problems, Bodily Pain, General Health Perceptions, Vitality, Social Functioning, Role Limitations due to Emotional Problems, and Mental Health. The scale scores range from 0 (worst health status) to 100 (best health status), with higher scores indicating a better quality of life.
Measured: one week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2026
- Study start1 Feb 2026
- Primary completion8 Mar 2026
- Study completion15 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Scapular WingingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study will be conducted as a randomized controlled trial. Participants will be randomly assigned to two groups: the intervention group (proprioceptive neuromuscular facilitation intervention) and the control group (no intervention).
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Manisa Celal Bayar University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Erhan Seçer, Manisa Celal Bayar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07344272
- Sponsor's protocol ID
- CBU-FTR-ES-O7
- Status last verified
- Sep 2026
- First submitted
- 7 Jan 2026
- Last updated
- 4 Sep 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Proprioceptive Neuromuscular Facilitation on Shoulder Girdle Function and Quality of Life in Individuals With Scapular Winging
- ClinicalTrials.gov ID
- NCT07344272
- Acronym / sponsor ID
- CBU-FTR-ES-O7
- Conditions
- Scapular Winging
- Keywords
- Functional status, Neuromuscular effect, Proprioceptive neuromuscular facilitation, Quality of life, Scapula
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Manisa Celal Bayar UniversityUniversity, hospital or other
- Study start
- 1 Feb 2026 (actual)
- Primary completion
- 8 Mar 2026 (actual)
- Study completion
- 15 Mar 2026 (actual)
- First posted
- 15 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effects of proprioceptive neuromuscular facilitation (PNF) on shoulder girdle function and quality of life in individuals with scapular winging.
Detailed description
Scapular stability on the thorax is fundamental for maintaining proper upper extremity function. The loss of this stability manifests clinically as scapular winging, a pathological condition characterized by the prominent protrusion of the medial (vertebral) border and/or the inferior angle of the scapula away from the thorax.
PNF can target the underlying impairment of scapular dysfunction by activating the muscle synergies required for scapulothoracic stability more powerfully and coordinately through resisted diagonal movements.
Therefore, the implementation and testing of PNF protocols are of critical importance, as this method can enhance functional strength and coordination, contributing to better clinical outcomes and improved quality of life in individuals with scapular winging.
Therefore, this study aims to investigate the effects of PNF on shoulder girdle function and quality of life in individuals with scapular winging.
In this study, designed as a randomized controlled trial, one group will receive PNF in scapular diagonals for approximately 20-30 minutes, three days a week, for a total of five weeks, to ensure scapular positioning and increase the tone of the surrounding muscles.
The control group will receive no intervention during this period.
Before (pre-test) and after (post-test) the study, participants in both groups will be evaluated using the Scapular Isometric Pinch Test for scapular muscle endurance; the Lateral Scapular Slide Test for scapular position; the Rounded Shoulder Posture Assessment for shoulder posture; the Disabilities of the Arm, Shoulder, and Hand Questionnaire for upper extremity functional level; and the Short Form-36 for quality of life.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- This study will be conducted as a randomized controlled trial. Participants will be randomly assigned to two groups: the intervention group (proprioceptive neuromuscular facilitation intervention) and the control group (no intervention).
| Arm | Type | Receives |
|---|---|---|
| Proprioceptive Neuromuscular Facilitation Group | Active comparator | Other: Proprioceptive neuromuscular facilitationThe Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes. |
| Control Group | No intervention | –The Control Group will receive no intervention. |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Volunteering to participate in the study.
- Presenting with bilateral scapular winging (Scapular winging will be evaluated by measuring the distance between the inferior angle of the scapula and the thoracic wall using a scapulometer; a distance of ≥2 cm is considered as winging).
Key exclusion criteria (4 listed)
- Presence of long thoracic nerve palsy.
- Having undergone shoulder surgery within the last 12 months or having an acute shoulder injury (e.g., rotator cuff tear, dislocation, labral pathology, etc.).
- Presence of scapulothoracic bursitis, fractures, tumors, or structural deformities in the scapular/thoracic region.
- Having received regular scapular or shoulder rehabilitation within the last 6 months.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Proprioceptive neuromuscular facilitationThe Proprioceptive Neuromuscular Facilitation Group will receive proprioceptive neuromuscular facilitation for a duration of 5 weeks, scheduled three times per week, with a session length of approximately 20-30 minutes. | Other | Proprioceptive Neuromuscular Facilitation Group |
Primary outcome
Biodex System 3 Pro
Time frame: one week
Isokinetic strength measurement of the shoulder girdle muscles will be performed using a Biodex System 3 Pro isokinetic dynamometer. The measurements will be conducted in a diagonal plane specifically determined to align with scapular patterns, utilizing a concentric-concentric mode at two different angular velocities: 60°/s and 180°/s. For each test, participants will perform three trial sets; the peak torque values obtained from each set will be normalized to body weight (Nm/kg) and averaged for statistical analysis. During the test protocol, participants will be securely positioned using stabilization straps to ensure arm and trunk stability. Prior to the measurements, a device orientation and warm-up session (e.g., three practice/familiarization sets) will be conducted, followed by the actual data collection.
4 secondary outcomes
Scapular Isometric Pinch Test
Time frame: one week
The Lateral Scapular Slide Test
Time frame: one week
Disabilities of the Arm, Shoulder, and Hand Questionnaire
Time frame: one week
Short Form-36
Time frame: one week
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Sep 2026.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Proprioceptive neuromuscular facilitation in people with Scapular Winging, run by Manisa Celal Bayar University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Biodex System 3 Pro (time frame: one week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.